Petros Pharmaceuticals, Inc. (PTPI) Operating cash flow 2020–2025
Petros Pharmaceuticals, Inc. (PTPI) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$6.7MFY2025 · since FY2020: -$15.3M → -$6.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$6.7M | -158.7% |
| FY2024 | -$2.6M | +65.9% |
| FY2023 | -$7.6M | +40.4% |
| FY2022 | -$12.8M | -7.9% |
| FY2021 | -$11.9M | +22.5% |
| FY2020 | -$15.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More PTPI financial trends
PTPI RevenuePTPI Net incomePTPI Net marginPTPI Gross profitPTPI Gross marginPTPI Operating incomePTPI Operating marginPTPI Free cash flowPTPI Capital expendituresPTPI Return on equityPTPI Stock buybacksPTPI Dividends paidPTPI Total assetsPTPI Total liabilitiesPTPI Shareholders’ equityPTPI overview →